课题基金 / 基金详情

项目摘要

项目成果

DENIS J GOSPODAROWICZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objective is to investigate the physiological function of a newly identified vascular endothelial cell mitogen (VEGF). We will analyze whether agents known to modulate the bioactivity of FGF also act at the VEGF level. These agents are a diverse group, including growth factors such as TGFbeta or TNFalpha, as well as unrelated molecules, such as heparin, suramin, and protamine, known to affect the angiogenic process and vascular endothelial cells proliferation. The ability of VEGF to control events related to the angiogenic process will be determined. This includes its effect on the chemotactic activity of vascular endothelial cells and its ability to stimulate plasminogen activator and collagenase, while repressing plasminogen inhibitor activity. We will study the expression of VEGF in normal versus tumor cell types. The various normal cell types to be looked at for VEGF expression are vascular endothelial and smooth muscle cells, platelet, monocytic cells, macrophages, and granulosa cells. These cell types are chosen because of their particular relevance to the angiogenic process. If expressed, VEGF could play a role in controlling developmental processes (angiogenesis, vasculogenesis), as well as a pathological one (atherosclerosis). Among the tumor cell types to be analyzed will be those derived from the vascular systems, as well as glioma cells. To study the effect of unregulated VEGF and betaFGF expression on developmental processes, chick embryos will be infected with avian retrovirus carrying the VEGF and betaFGF gene. The tissue specific pattern of viruses expressing the VEGF and betaFGF gene will then be followed as a function of time. This will be correlated with abnormality of development, particularly in the vascular system. We will define the cell surface receptor for VEGF. This is the first step toward cloning of the receptor, as well as a step towards understanding the molecular mechanism of the cells response to this growth factor.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1083/jcb.89.3.568
发表时间: 1981-06
期刊: The Journal of cell biology
影响因子: --
作者: [Gospodarowicz D, Hirabayashi K, Giguère L, Tauber JP]
通讯作者: Tauber JP
Protamine sulfate inhibits mitogenic activities of the extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor.
硫酸鱼精蛋白抑制细胞外基质和成纤维细胞生长因子的有丝分裂活性,但增强表皮生长因子的有丝分裂活性。
DOI: 10.1002/jcp.1041320213
发表时间: 1987
期刊: Journal of cellular physiology
影响因子: 5.6
作者: [Neufeld,G, Gospodarowicz,D]
通讯作者: Gospodarowicz,D
Biotin and choline replace the growth requirement of Madin-Darby canine kidney cells for high-density lipoproteins.
生物素和胆碱替代了 Madin-Darby 犬肾细胞对高密度脂蛋白的生长需求。
DOI: 10.1002/jcp.1041240116
发表时间: 1985
期刊: Journal of cellular physiology
影响因子: 5.6
作者: [Cohen,DC, Gospodarowicz,D]
通讯作者: Gospodarowicz,D
Stimulation of the proliferation of the Madin-Darby canine kidney (MDCK) epithelial cell line by high-density lipoproteins and their induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.
高密度脂蛋白刺激 Madin-Darby 犬肾 (MDCK) 上皮细胞系的增殖及其诱导 3-羟基-3-甲基戊二酰辅酶 A 还原酶活性。
DOI: 10.1002/jcp.1041170112
发表时间: 1983
期刊: Journal of cellular physiology
影响因子: 5.6
作者: [Gospodarowicz,D, Cohen,DC, Massoglia,SL]
通讯作者: Massoglia,SL
7
    REGULATION OF CHOLESTEROL IN VASCULAR ENDOTHELIUM
    REGULATION OF CHOLESTEROL IN VASCULAR ENDOTHELIUM
    REGULATION OF CHOLESTEROL IN VASCULAR ENDOTHELIUM
    REGULATION OF CHOLESTEROL IN VASCULAR ENDOTHELIUM
    国内基金
    海外基金
    ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
    • 批准号:
      81200692
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2012
    • 负责人:
      陈凌
    • 依托单位: